Cost-effectiveness analysis of deep vein thrombosis prophylaxis in internal medicine patients.
Wade
W E
WE
College of Pharmacy, University of Georgia, Athens 30602, USA. BWADE@rx.uga.edu
Chisholm
M A
MA
D003362:Cost-Benefit Analysis; D006493:Heparin / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D020246:Venous Thrombosis / Q000191:economics / Q000517:prevention & control*
D006495:Heparin, Low-Molecular-Weight; D006493:Heparin